Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance

Author(s): S. Trabanelli, D. Ocadlikova, C. Evangelisti, S. Parisi and A. Curti

Volume 18, Issue 15, 2011

Page: [2234 - 2239] Pages: 6

DOI: 10.2174/092986711795656054

Price: $65

Abstract

Indoleamine 2,3-dioxygenase (IDO) is an intracellular heme-containing enzyme that catalyzes the initial rate-limiting step in tryptophan degradation along the kynurenine pathway. Recent works have demonstrated a crucial role for IDO in the induction of immune tolerance during infections, pregnancy, transplantation, autoimmunity, and neoplasias. IDO is widely expressed in human tissues and cell subsets, including dendritic cells, where it modulates their function by increasing tolerogenic capacities. The aim of the present paper is to highlight the most recent data about IDO expression in dendritic cells and its role as a potent inducer of T regulatory cells.

Keywords: T regulatory cells, indoleamine 2,3-dioxygenase, dendritic cells, intracellular heme-containing enzyme, tryptophan degradation, kynurenine, IDO, immune tolerance, neoplasias, tolerogenic capacities


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy